KOD Kodiak Pharma: Pangali EV/EBITDA

Logo korporat perusahaan Kodiak Pharma (KOD)

Kodiak Sciences Inc. (KOD) is deploying capital toward ophthalmology research without current sales. Meanwhile, the company's biopolymer developments reduce the number of injections, simplifying the treatment of blindness. Past trial failures create risks despite cost optimization. The EV/EBITDA valuation trend demonstrates the asset's volatility, where 0.00 records a new level mark.

KOD Kodiak Pharma: Rasio total nilai perusahaan marang bathi operasional sadurunge panyusutan ing interval 23.11.2025 - 16.11.2026

KOD (Kodiak Sciences): rincian analitis lan laporan miturut indikator

Pambiji fundamental perusahaan:kodiak.com KOD
Produk asli kodiak.com

Developing the unique ABC biopolymer platform for retinal therapy requires colossal capital expenditures, making the business value dependent on debt load and operational efficiency. By analyzing the EV/EBITDA history of Kodiak Sciences Inc. (KOD), an investor can see the ratio of total enterprise value to earnings before interest, taxes, depreciation, and amortization, which allows for an assessment of the company's real value considering its loans and technological barriers.

Analisis perusahaan pesaing

Alcon Inc - Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan|Bausch + Lomb (BLCO) - Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan|GKOS: Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Apellis|BLTE: Pangali EV/EBITDA|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Ocular Pharma (OCUL)|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan harrowinc.com|Viridian Therapeutics, Inc. (VRDN) - Rasio total nilai perusahaan marang bathi operasional sadurunge panyusutan|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan LENZ Therapeutics (LENZ)|Pangali EV/EBITDA Oculis AG (OCS)|eyepointpharma.com - Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan|Aldeyra - Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan|KALA - Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan|Rasio total nilai perusahaan marang bathi operasional sadurunge panyusutan Opus Genetics, Inc. IRD|okyopharma.com (OKYO) - Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Adverum (ADVM)|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan outlooktherapeutics.com|CLSD: Nilai bisnis marang bathi operasional sadurunge panyusutan|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan NBY (NovaBay Pharmaceuticals)|KPRX (Kiora Pharmaceuticals Inc.) - Nilai bisnis marang bathi operasional sadurunge panyusutan|Pangali EV/EBITDA ALIM (Alimera Sciences Inc)|Rasio total nilai perusahaan marang bathi operasional sadurunge panyusutan Eyenovia Corp (EYEN)|GHSI - Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Ocuphire Pharma, Inc.|opthea.com (OPT) - Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan